PCM
BLUE

Penserra Capital Management’s bluebird bio BLUE Stock Holding History

Penserra Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-686
Closed -$56K – 1003
2022
Q2 		$56K Buy
686
+135
+25% +$10.5K ﹤0.01% 883
2022
Q1 		$53K Buy
+551
New +$72.7K ﹤0.01% 981
2021
Q4 		– Sell
-119
Closed -$29K – 1389
2021
Q3 		$29K Hold
119
– – ﹤0.01% 1186
2021
Q2 		$49K Buy
119
+2
+2% +$792 ﹤0.01% 1001
2021
Q1 		$45K Sell
117
-2
-2% -$985 ﹤0.01% 826
2020
Q4 		$66K Buy
119
+75
+170% +$47.5K ﹤0.01% 651
2020
Q3 		$30K Sell
44
-91
-67% -$71K ﹤0.01% 689
2020
Q2 		$106K Buy
+135
New +$102K 0.01% 547

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Penserra Capital Management's BLUE Position: Q3 2022 in Review

Penserra Capital Management sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 686 shares — an estimated $56K sold.

Penserra Capital Management first reported a position in BLUE in Q2 2020 and held it in 8 quarters. The position peaked at $106K in Q2 2020. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

  • Penserra Capital Management reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 686 bluebird bio shares in Q3 2022, an estimated $56K.
  • Penserra Capital Management first reported a position in bluebird bio in Q2 2020 and held it in 8 quarters.
  • Penserra Capital Management's bluebird bio position peaked at $106K in Q2 2020.
  • 162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.